This site displays a prototype of a “Web 2.0” version of the daily Federal Register. It is not an official legal edition of the Federal Register, and does not replace the official print version or the official electronic version on GPO’s govinfo.gov.
If you are looking for more details, kindly visit what is pmk ethyl glycidate.
The documents posted on this site are XML renditions of published Federal Register documents. Each document posted on the site includes a link to the corresponding official PDF file on govinfo.gov. This prototype edition of the daily Federal Register on FederalRegister.gov will remain an unofficial informational resource until the Administrative Committee of the Federal Register (ACFR) issues a regulation granting it official legal status. For complete information about, and access to, our official publications and services, go to About the Federal Register on NARA's archives.gov.
The OFR/GPO partnership is committed to presenting accurate and reliable regulatory information on FederalRegister.gov with the objective of establishing the XML-based Federal Register as an ACFR-sanctioned publication in the future. While every effort has been made to ensure that the material on FederalRegister.gov is accurately displayed, consistent with the official SGML-based PDF version on govinfo.gov, those relying on it for legal research should verify their results against an official edition of the Federal Register. Until the ACFR grants it official status, the XML rendition of the daily Federal Register on FederalRegister.gov does not provide legal notice to the public or judicial notice to the courts.
PMK ethyl glycidate can be used as organic synthesis intermediate and pharmaceutical intermediate, mainly used in laboratory research and development process and pharmaceutical chemical production process.
Fig. 1 The synthetic step 1 of PMK ethyl glycidate.
To a solution of piperonal (1, 3.00 g, 19.9 mmol) in CH2Cl2 (100 mL) was added (carbethoxyethylidene)triphenylphosphorane (2,14.5 g, 40.0 mmol), and the reaction mixture was stirred for 24 h at room temperature. The mixture was then concentrated at reduced pressure, and the residue was purified by flash column chromatography on silica gel (hexanes/EtOAc,10:1) to afford olefin 3 (4.45 g, 95%) as a colorless oil: 1H NMR (400 MHz, CDCl3) d 7.58 (s, 1H), 6.92 (d, J = 1.7 Hz, 1H), 6.90 (dd, J = 7.9, 1.7 Hz, 1H), 6.82 (d, J = 8.0 Hz, 1H), 5.97 (s, 2H), 4.24 (q, J = 7.1 Hz, 2H), 2.10 (d, J = 1.6 Hz, 3H),1.33 (t, J = 7.1 Hz, 3H); 13C NMR (100 MHz, CDCl3) d 168.7,147.6, 138.3, 129.9, 126.9, 124.6, 109.5, 108.2, 101.2, 60.7, 14.3,1 4.0; IR (ATR, cm-1): 2981, 2902,1698, 1628, 1502, 1489,1442, 1258, 1224; HRMS (EI) m/z calcd for C13H14O4 (M+) 234.0892, found 234.0895 [1].
If you want to learn more, please visit our website wholesale 2-iodo-1-p-tolylpropan-1-one powder.
Fig. 2 The synthetic step 2 of PMK ethyl glycidate.
To a solution of olefin 3 (3.00 g, 12.8 mmol) in CH2Cl2 (80 mL) was added 50–55% m-chloroperbenzoic acid (6.2 g,17.9 mmol). The reaction mixture was refluxed for 24 h, cooled to room temperature, quenched with 10% aqueous sodium sulfite (30 mL), and diluted with CH2Cl2 (100 mL). The organic layer was separated, and the aqueous layer was extracted with CH2Cl2 (2 × 30 mL). The combined organic layers were washed with saturated aqueous NaHCO3 and brine, dried over anhydrous MgSO4, and concentrated at reduced pressure. The resulting residue was purified by flash column chromatography on silica gel (hexanes/EtOAc, 10:1) to afford epoxide 4 (2.12 g, 66%) as a colorless oil: 1H NMR (400 MHz, CDCl3) d 6.79 (d, J = 1.6 Hz, 2H), 6.76 (s, 1H), 5.96 (d, J = 1.6 Hz, 2H), 4.30–4.17 (m, 2H), 4.21 (s, 1H), 1.31 (ddd, J = 8.8, 8.8, 1.7 Hz, 6H); 13C NMR (100 MHz, CDCl3) d 170.8, 147.7, 147.6, 127.6, 120.3, 108.2, 107.0, 101.2, 62.2, 61.8, 59.9, 14.1, 12.5; IR (ATR, cm-1) 2982, 2903, 1726, 1504, 1492, 1444, 1281, 1240; HRMS (EI) m/z calcd for C13H14O5 (M+) 250.0841, found 250.0837 [1].
PMK ethyl glycidate as an intermediate in the synthesis of M-ALPHA analog and MDMA. The widespread abuse of illicit psychoactive substances is one of the most serious public health and social problems. A suspicious airmail package was seized by Korean customs, and two psychoactive substances in the grayish-green pills in the package were detected by ultra-performance liq. chromatog. The structures of the two substances were elucidated by a combination of liq. chromatog. quadrupole time-of-flight mass spectrometry, NMR spectroscopy, and comparison with reported or newly generated spectral data of the suggested structures. One of the psychoactive substances proved to be MDMA (commonly known as "Ecstasy"), and the other compd. was an M-ALPHA analog bearing a hydroxyl group and an N-methylcarboxamide group. The new M-ALPHA analog was detd. as 3-(benzo[d][1,3]dioxol-5-yl)-2-hydroxy-N,2-dimethyl-3-(methylamino)propanamide and named as M-ALPHA-HMCA, wherein HMCA denotes hydroxymethylcarboxamide. Although psychoactivity of this compd. has not been assessed, M-ALPHA-HMCA should be considered a potential new psychoactive substance and/or a byproduct of MDMA [1].
PMK ethyl glycidate as an intermediate in the synthesis of desoxy phenethylamine analogs. The desoxy phenethylamine analogs in this study represent a combination of alkyl side-chain and cyclic amines (azetidine, pyrrolidine, piperidine and azepane) to yield a set of mols. of identical elemental compn. as well as major mass spectral fragment ions (base peaks) of identical elemental compn. These desoxy phenethylamine analogs of the aminoketone designer drug, 3,4-methylenedioxy-pyrrovalerone (MDPV) related to the natural product cathinone were prepd. from piperonal (3,4-methylenedioxybenzaldehyde) via the intermediate precursor ketones. The aminoketones and the desoxy phenethylamine regioisomers were each sepd. in capillary gas chromatog. expts. using an Rxi-7Sil MS stationary phase with the aminoketones showing greater retention than the corresponding desoxyamines[2].
[1] Lee J H, Park O R, Mandava S, et al. Identification of a new M-ALPHA analog and MDMA in an illegal health product[J]. Forensic science international, 2020, 313: 110332.
[2] Abiedalla Y, DeRuiter J, Clark C R. GC–MS, GC–MS/MS and GC-IR differentiation of desoxy cathinone derivatives: cyclic tertiary amines related to MDPV[J]. Journal of Chromatography B, 2017, 1048: 38-48.
For more 236117-38-7information, please contact us. We will provide professional answers.